Formulation and evaluation of itraconazole via liquid crystal for topical delivery system.
about
Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery.Novel lecithin-integrated liquid crystalline nanogels for enhanced cutaneous targeting of terconazole: development, in vitro and in vivo studies.Topical delivery of antifungal agents.Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)Topical application of retinyl palmitate-loaded nanotechnology-based drug delivery systems for the treatment of skin aging.Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.Formulation and evaluation of Ketoconazole niosomal gel drug delivery systemEnhanced topical delivery of terbinafine hydrochloride with chitosan hydrogelsQuercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.Skin delivery of kojic acid-loaded nanotechnology-based drug delivery systems for the treatment of skin agingItraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans.Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations.Preparation and valuation of a topical solution containing eutectic mixture of itraconazole and phenol.In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
P2860
Q36442112-8E67CA9C-23E9-4243-B4F3-6E029BBCB69FQ37249022-BE00B2BF-C887-4B80-863C-C5EE0E91A48DQ37381451-B64BC864-AEE5-4301-8ABA-A13EB4515835Q37801662-21EF63AE-5ADD-4EDD-8069-F90B261F3597Q38619498-8DA51A0A-01F9-4B4A-B33C-70B0B209E3E0Q38632270-7B023E50-DBF6-4E0C-B448-EEDB7DAC7D5FQ38938549-13BF2855-016A-4D95-BEEF-216A3CD9A636Q39650047-C6DD9CDE-AE98-4683-BC97-EE19EA746379Q41925295-BC25538D-4359-4FE7-B559-D5E8EB6C51DCQ41989604-1BCAC2D1-6C0D-4665-8C8F-CCF6FDAF4D33Q42265539-8A556682-D316-4685-8CA7-468A91BBC34DQ42429675-D2625A9F-420F-4D54-BB4C-0C425F542A1EQ45827964-3100470A-D55D-4216-A5F2-9E0261E9104DQ46984154-DF32F26D-F6CD-4144-907F-533DBE2EA9A2Q48110169-5E4293DF-FBB8-4DEA-89A9-B46139EAE753Q52092764-13ECB7EE-8093-4AFC-8D3B-B4FE4A5BFDF2Q57492599-1E8EE191-B7D2-42EE-9964-A59A76954C4F
P2860
Formulation and evaluation of itraconazole via liquid crystal for topical delivery system.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Formulation and evaluation of ...... l for topical delivery system.
@ast
Formulation and evaluation of ...... l for topical delivery system.
@en
type
label
Formulation and evaluation of ...... l for topical delivery system.
@ast
Formulation and evaluation of ...... l for topical delivery system.
@en
prefLabel
Formulation and evaluation of ...... l for topical delivery system.
@ast
Formulation and evaluation of ...... l for topical delivery system.
@en
P1476
Formulation and evaluation of ...... l for topical delivery system.
@en
P2093
Nesseem DI
P304
P356
10.1016/S0731-7085(01)00414-9
P577
2001-10-01T00:00:00Z